Evidence map›Paper›PMID 29097941›Full record

ArticleContrast media & molecular imaging2017

Use of Ultrasmall Superparamagnetic Iron Oxide Enhanced Susceptibility Weighted Imaging and Mean Vessel Density Imaging to Monitor Antiangiogenic Effects of Sorafenib on Experimental Hepatocellular Carcinoma.

Shuohui Yang, Jiang Lin, Fang Lu, Zhihong Han, Caixia Fu, Hongchen Gu

Open access · hybridAbstract read
In one paragraph

Article in Contrast media & molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Radiomics Analysis of Susceptibility Weighted Imaging for Hepatocellular Carcinoma: Exploring the Correlation between Histopathology and Radiomics Features.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2021
    Article
  5. Review
  6. Journal of nanobiotechnology · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Shuohui YangDepartment of Radiology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai Institute of Medical Imaging, Shanghai 200032, China.ORCID 0000-0002-2866-9529
Jiang LinDepartment of Radiology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai Institute of Medical Imaging, Shanghai 200032, China.ORCID 0000-0002-6593-9700
Fang LuDepartment of Radiology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China.ORCID 0000-0003-1247-1523
Zhihong HanDepartment of Pathology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200021, China.ORCID 0000-0003-2264-3712
Caixia FuSiemens Shenzhen Magnetic Resonance Ltd., Shenzhen 518057, China.ORCID 0000-0002-5595-6347
Hongchen GuSchool of Biomedical Engineering, Med-X Research Institute, Shanghai Jiao Tong University, Shanghai 200030, China.ORCID 0000-0001-8009-2459
Shanghai Medical College of Fudan University · CNShanghai University of Traditional Chinese Medicine · CNShanghai Jiao Tong University · CNSiemens (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated effectiveness of ultrasmall superparamagnetic iron oxide enhanced susceptibility weighted imaging (USPIO-enhanced SWI) and mean vessel density imaging (

Indexed as

Liver NeoplasmsAngiogenesis InhibitorsAnimalsCarcinoma, HepatocellularFerric CompoundsHeterograftsHumansMagnetic Resonance ImagingMiceNeovascularization, PathologicNiacinamidePhenylurea CompoundsSorafenibAngiogenesis InhibitorsFerric Compoundsferric oxideNiacinamidePhenylurea CompoundsSorafenib

Identifiers

PMID29097941
PMCPMC5612611
OpenAlexW2667332699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.